相关实验视频

Updated: Jan 18, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

临床前痴呆症评级得分与血酸化tau-217相关

Qi Huang^1,2, Erin M Jonaitis^2,3, Rachel L Studer^2,4

¹Department of Educational Studies Purdue University College of Education West Lafayette Indiana USA.

Alzheimer's & dementia (Amsterdam, Netherlands)

|September 10, 2025

概括

快速痴呆评级系统 (QDRS) 有效地跟踪阿尔茨海默氏病 (AD) 进展在高pTau217.7.个体. 较高的生物标志物水平与更快的认知和功能衰退相关,验证了QDRS在痴呆前阶段的实用性.

科学领域:

神经科学是一个神经科学.
生物标志物生物标志物
老年学是一门学科.

背景情况:

早期发现阿尔茨海默氏病 (AD) 的变化是非常重要的.
需要简单的选工具来评估这些早期变化.
血pTau217是AD病理学的有前途的生物标志物.

研究的目的:

调查基线血pTau217水平与快速痴呆评级系统 (QDRS) 和临床前阿尔茨海默氏症认知组合 (PACC3) 的纵向变化之间的关系.
评估血pTau217是否改变了基线没有痴呆症的个体的认知和功能衰退轨迹.

主要方法:

利用了来自威斯康星州预防阿尔茨海默病登记处的数据 (N=639).
采用混合效应模型来分析QDRS和PACC3轨迹的时间 (年龄).
研究了pTau217*年龄相互作用效应,以了解生物标志物对衰退的影响.

主要成果:

较高的基线血pTau217水平与QDRS测量的加速功能衰退显著相关.
通过PACC3评估的认知衰退,在pTau217.217.高的人群中也显示出更快的进展.
在QDRS和PACC3之间,下降效应大小是可比的,表明敏感度相似.
探索性分析显示,过渡到受损QDRS分类的风险增加,基线高pTau217.

结论:

快速痴呆评级系统 (QDRS) 是监测阿尔茨海默病前痴呆阶段功能衰退的宝贵工具.
血pTau217作为一个显著的预测器,在两个认知和功能下降的个体有风险为AD.
这些发现支持QDRS和pTau217的联合使用,用于早期AD评估和跟踪.

关键词:

作为一种AD生物标志物.快速痴呆症评级系统 (QDRS) 是一个快速痴呆症评级系统.化217 (pTau217) 化217 (pTau217) 化217 (pTau217) 化217 (pTau217) 化217 (pTau217) 化217) 化217 (pTau217) 化217 (pTau217) 化217) 化217 (pTau217) 化217 (pTau217) 化217) 化217 (pTau217) 化217 (pTau217) 化217 (pTau217) 化217) 化217 (pTau217) 化217) 化217 (pTau217) 化217 (pTau217) 化217 (pTau217) 化217) 化217 (pTau217) 化217) 化217 (pTau217) 化217

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...